Enzo Biochem Shares Outstanding 2006-2019 | ENZ

Enzo Biochem shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Enzo Biochem Annual Shares Outstanding
(Millions of Shares)
2018 47
2017 46
2016 47
2015 45
2014 43
2013 40
2012 39
2011 38
2010 38
2009 38
2008 37
2007 35
2006 32
2005 33
Enzo Biochem Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 48
Q2 2019 47
Q1 2018 47
Q4 2018 47
Q3 2018 47
Q2 2018 47
Q1 2017 47
Q4 2017 46
Q3 2017 46
Q2 2017 46
Q1 2016 46
Q4 2016 47
Q3 2016 46
Q2 2016 47
Q1 2015 46
Q4 2015 45
Q3 2015 46
Q2 2015 45
Q1 2014 45
Q4 2014 43
Q3 2014 43
Q2 2014 42
Q1 2013 41
Q4 2013 40
Q3 2013 40
Q2 2013 39
Q1 2012 39
Q4 2012 39
Q3 2012 39
Q2 2012 39
Q1 2011 39
Q4 2011 38
Q3 2011 38
Q2 2011 38
Q1 2010 38
Q4 2010 38
Q3 2010 38
Q2 2010 38
Q1 2009 38
Q4 2009 38
Q3 2009 37
Q2 2009 37
Q1 2008 37
Q4 2008 37
Q3 2008 37
Q2 2008 37
Q1 2007 37
Q4 2007 35
Q3 2007 37
Q2 2007 34
Q1 2006 32
Q4 2006 32
Q3 2006 32
Q2 2006 32
Q1 2005 32
Q4 2005 33
Q3 2005 32
Q2 2005 32
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.179B $0.105B
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.995B 12.21
Gilead Sciences (GILD) United States $85.316B 10.36
Celgene (CELG) United States $64.087B 10.86
Vertex Pharmaceuticals (VRTX) United States $45.369B 54.84
Illumina (ILMN) United States $44.526B 51.60
Biogen (BIIB) United States $44.487B 8.44
CSL (CSLLY) Australia $35.586B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.719B 15.38
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $27.673B 15.66
Incyte (INCY) United States $17.204B 69.76
Exact Sciences (EXAS) United States $15.024B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.768B 0.00
SINO PHARMACEUT (SBMFF) China $14.154B 0.00
Seattle Genetics (SGEN) United States $12.157B 0.00
Sarepta Therapeutics (SRPT) United States $11.420B 0.00
Genmab (GNMSF) Denmark $11.291B 57.40
Array BioPharma (ARRY) United States $10.322B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.283B 49.21
QIAGEN (QGEN) Netherlands $8.926B 29.32
Galapagos (GLPG) Belgium $8.704B 0.00
Guardant Health (GH) United States $8.043B 0.00
Bio-Techne Corp (TECH) United States $7.954B 54.27
Alnylam Pharmaceuticals (ALNY) United States $7.743B 0.00
Bluebird Bio (BLUE) United States $7.687B 0.00
Amarin (AMRN) Ireland $6.968B 0.00
Exelixis (EXEL) United States $6.551B 16.70
BeiGene (BGNE) Cayman Islands $5.653B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.786B 0.00
Ascendis Pharma (ASND) Denmark $4.751B 0.00
Blueprint Medicines (BPMC) United States $4.706B 0.00
Moderna (MRNA) United States $4.616B 0.00
Horizon Pharma Public (HZNP) Ireland $4.491B 11.57
Repligen (RGEN) United States $4.118B 102.59
Spark Therapeutics (ONCE) United States $3.727B 0.00
Mirati Therapeutics (MRTX) United States $3.724B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.686B 0.00
China Biologic Products (CBPO) China $3.670B 23.31
Alkermes (ALKS) Ireland $3.623B 0.00
MorphoSys AG (MOR) Germany $3.446B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.416B 0.00
Arena Pharmaceuticals (ARNA) United States $3.040B 6.18
Amicus Therapeutics (FOLD) United States $2.924B 0.00
Immunomedics (IMMU) United States $2.871B 0.00
UniQure (QURE) Netherlands $2.738B 0.00
Medicines (MDCO) United States $2.704B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.605B 0.00
Reata Pharmaceuticals (RETA) United States $2.529B 0.00
Halozyme Therapeutics (HALO) United States $2.439B 0.00
MyoKardia (MYOK) United States $2.295B 0.00
NeoGenomics (NEO) United States $2.282B 149.38
Nabriva Therapeutics AG (NBRV) Ireland $2.260B 0.00
Ligand Pharmaceuticals (LGND) United States $2.210B 18.31
Acceleron Pharma (XLRN) United States $2.199B 0.00
Emergent Biosolutions (EBS) United States $2.180B 18.93
Zai Lab (ZLAB) China $2.109B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.078B 0.00
Akcea Therapeutics (AKCA) United States $2.063B 0.00
Genomic Health (GHDX) United States $2.044B 43.42
Myriad Genetics (MYGN) United States $1.930B 19.20
Denali Therapeutics (DNLI) United States $1.917B 0.00
REGENXBIO (RGNX) United States $1.749B 0.00
Insmed (INSM) United States $1.672B 0.00
Cambrex (CBM) United States $1.510B 19.10
AnaptysBio (ANAB) United States $1.457B 0.00
Fate Therapeutics (FATE) United States $1.451B 0.00
RA PHARMCTL INC (RARX) United States $1.379B 0.00
Innoviva (INVA) United States $1.365B 3.78
Sangamo Therapeutics (SGMO) United States $1.364B 0.00
Athenex (ATNX) United States $1.286B 0.00
Alector (ALEC) United States $1.256B 0.00
Coherus BioSciences (CHRS) United States $1.233B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.187B 0.00
Editas Medicine (EDIT) United States $1.184B 0.00
Epizyme (EPZM) United States $1.142B 0.00
Cara Therapeutics (CARA) United States $1.070B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.023B 0.00
Codexis (CDXS) United States $1.022B 0.00
Twist Bioscience (TWST) United States $0.978B 0.00
Adverum Biotechnologies (ADVM) United States $0.978B 0.00
Principia Biopharma (PRNB) United States $0.974B 0.00
ANI Pharmaceuticals (ANIP) United States $0.973B 17.26
Momenta Pharmaceuticals (MNTA) United States $0.959B 0.00
Zymeworks (ZYME) Canada $0.940B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.924B 0.00
WAVE Life Sciences (WVE) Singapore $0.907B 0.00
Retrophin (RTRX) United States $0.879B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.866B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.856B 0.00
Vericel (VCEL) United States $0.853B 0.00
Arvinas (ARVN) United States $0.772B 0.00
Intellia Therapeutics (NTLA) United States $0.763B 0.00
Precision BioSciences (DTIL) United States $0.746B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.704B 33.22
Zealand Pharma (ZEAL) Denmark $0.704B 8.22
Zealand Pharma (ZLDPF) Denmark $0.683B 0.00
Cytokineticsorporated (CYTK) United States $0.670B 0.00
Clovis Oncology (CLVS) United States $0.654B 0.00
Intra-Cellular Therapies (ITCI) United States $0.643B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.639B 0.00
Cellectis S.A (CLLS) France $0.635B 0.00
Heska (HSKA) United States $0.622B 63.73
DBV Technologies S.A (DBVT) France $0.596B 0.00
Anika Therapeutics (ANIK) United States $0.581B 19.84
Stemline Therapeutics (STML) United States $0.580B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.569B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.560B 0.00
Revance Therapeutics (RVNC) United States $0.557B 0.00
CytomX Therapeutics (CTMX) United States $0.549B 0.00
MiMedx (MDXG) United States $0.525B 0.00
Pharming Group (PHGUF) Netherlands $0.521B 0.00
Mesoblast (MESO) Australia $0.494B 0.00
PHARMA MAR SA (PHMMF) Spain $0.453B 0.00
UROGEN PHARMA (URGN) United States $0.445B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.442B 0.00
Puma Biotechnology (PBYI) United States $0.405B 0.00
AC Immune SA (ACIU) Switzerland $0.398B 25.61
Prothena (PRTA) Ireland $0.389B 0.00
PDL BioPharma (PDLI) United States $0.379B 9.06
Arcus Biosciences (RCUS) United States $0.376B 0.00
Gritstone Oncology (GRTS) United States $0.372B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Biofrontera AG (BFRA) Germany $0.369B 0.00
Scholar Rock Holding (SRRK) United States $0.361B 0.00
Bellus Health (BLUSF) Canada $0.361B 0.00
Albireo Pharma (ALBO) United States $0.354B 0.00
Merus (MRUS) Netherlands $0.352B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.351B 0.00
Prometic Life Sciences (PFSCD) Canada $0.349B 0.00
BioDelivery Sciences (BDSI) United States $0.348B 0.00
Avid Bioservices (CDMO) United States $0.347B 0.00
Kadmon Holdings (KDMN) United States $0.344B 0.00
Starpharma Holdings (SPHRY) Australia $0.343B 0.00
Agenus (AGEN) United States $0.340B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.333B 0.00
Acorda Therapeutics (ACOR) United States $0.332B 5.85
Senesco Technologies (ELOX) United States $0.331B 0.00
Theratechnologies (THERF) Canada $0.330B 0.00
Syros Pharmaceuticals (SYRS) United States $0.322B 0.00
Protagonist Therapeutics (PTGX) United States $0.310B 0.00
Sorrento Therapeutics (SRNE) United States $0.307B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.292B 0.00
Cellular Biomedicine (CBMG) United States $0.275B 0.00
Kindred Biosciences (KIN) United States $0.269B 0.00
Inovio Pharmaceuticals (INO) United States $0.266B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.261B 0.00
Sutro Biopharma (STRO) United States $0.253B 0.00
ChromaDex (CDXC) United States $0.253B 0.00
PHASEBIO PHARMA (PHAS) United States $0.249B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.248B 0.00
Dynavax Technologies (DVAX) United States $0.247B 0.00
Kamada (KMDA) Israel $0.241B 9.36
Athersys (ATHX) United States $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.232B 0.00
Geron (GERN) United States $0.231B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.222B 0.00
Cel-Sci (CVM) United States $0.214B 0.00
CorMedix Inc (CRMD) United States $0.214B 0.00
Palatin Technologies (PTN) United States $0.211B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.206B 0.00
Cerecor (CERC) United States $0.199B 0.00
Five Prime Therapeutics (FPRX) United States $0.198B 0.00
Synlogic (SYBX) United States $0.196B 0.00
MannKind (MNKD) United States $0.195B 0.00
Abeona Therapeutics (ABEO) United States $0.193B 0.00
Mersana Therapeutics (MRSN) United States $0.191B 0.00
Affimed (AFMD) Germany $0.190B 0.00
Pfenex (PFNX) United States $0.187B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
Spero Therapeutics (SPRO) United States $0.185B 0.00
POXEL SA FRANCE (PXXLF) $0.184B 0.00
Compugen (CGEN) Israel $0.183B 0.00
Arsanis (XFOR) United States $0.180B 0.00
BioTime (BTX) United States $0.169B 11.30
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Nicox SA (NICXF) France $0.162B 0.00
XOMA (XOMA) United States $0.159B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.158B 0.00
Strongbridge Biopharma (SBBP) United States $0.157B 9.03
Cue Biopharma (CUE) United States $0.151B 0.00
Liquidia Technologies (LQDA) United States $0.144B 0.00
OvaScience (MLND) United States $0.142B 0.00
TOCAGEN INC (TOCA) United States $0.141B 0.00
Adocia (ADOCY) France $0.140B 0.00
Celyad SA (CYAD) Belgium $0.139B 0.00
Northwest Biotherapeutics (NWBO) United States $0.134B 0.00
Dyadic (DYAI) United States $0.133B 0.00
Seres Therapeutics (MCRB) United States $0.128B 0.00
NantKwest (NK) United States $0.125B 0.00
Aptinyx (APTX) United States $0.123B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.122B 0.00
Alcobra (ARCT) United States $0.119B 0.00
Aduro Biotech (ADRO) United States $0.118B 0.00
Arbutus Biopharma (ABUS) Canada $0.115B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
Verastem (VSTM) United States $0.110B 0.00
Checkpoint Therapeutics (CKPT) United States $0.110B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.109B 0.00
Menlo Therapeutics (MNLO) United States $0.108B 0.00
Novavax (NVAX) United States $0.107B 0.00
SESEN BIO, INC (SESN) United States $0.101B 0.00
Catalyst Biosciences (CBIO) United States $0.101B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.101B 0.00
Trevena (TRVN) United States $0.095B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.094B 0.00
Fortress Biotech (FBIO) United States $0.089B 0.00
Pluristem Therapeutics (PSTI) Israel $0.089B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.085B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.084B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.084B 0.00
Unum Therapeutics (UMRX) United States $0.079B 0.00
Selecta Biosciences (SELB) United States $0.078B 0.00
Curis (CRIS) United States $0.078B 0.00
AquaBounty Technologies (AQB) United States $0.076B 0.00
VBI Vaccines (VBIV) United States $0.076B 0.00
VTv Therapeutics (VTVT) United States $0.075B 0.00
Idera Pharmaceuticals (IDRA) United States $0.073B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
Applied Genetic Technologies (AGTC) United States $0.071B 38.80
Signal Genetics (MGEN) United States $0.070B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.065B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
ARAVIVE, INC (ARAV) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.061B 0.00
Antibe Therapeutics (ATBPF) Canada $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.059B 0.00
Prima BioMed (IMMP) Australia $0.059B 0.00
Invo BioScience (IVOB) United States $0.055B 0.00
NewLink Genetics (NLNK) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.051B 0.00